M.S. Hoogeman
Papers
1
Total Citations
51
H-Index
1
About
M.S. Hoogeman is a leading figure in radiation oncology, whose work has significantly advanced stereotactic body radiotherapy (SBRT), particularly for prostate cancer. Their research centers on the clinical implementation and technical refinement of high-precision, hypofractionated treatments using robotic radiosurgery systems like the CyberKnife. Hoogeman's major contribution is demonstrating the feasibility and excellent tolerance of CyberKnife SBRT as a monotherapy for low- to intermediate-stage prostate cancer, as detailed in their highly cited 2010 paper (51 citations). This work helped establish a new, non-invasive treatment paradigm that delivers potent, ultra-concentrated radiation doses in fewer sessions, dramatically shortening treatment times while minimizing damage to surrounding healthy tissue. By validating this approach, Hoogeman has directly improved patient quality of life and expanded access to advanced radiotherapy. Their research remains foundational for clinicians and physicists seeking to optimize dose conformity and organ-at-risk sparing in prostate SBRT, cementing their role as a key innovator in the field.
Research Focus
Key Achievements
Top Papers
- 1